{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:06:14Z","timestamp":1792073174167,"version":"4.4.0"},"reference-count":45,"publisher":"University of Tokushima Faculty of Medicine","issue":"3.4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Invest."],"published-print":{"date-parts":[[2023]]},"DOI":"10.2152\/jmi.70.403","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T22:14:55Z","timestamp":1699481695000},"page":"403-410","source":"Crossref","is-referenced-by-count":4,"title":["Molecular species profiles of plasma ceramides in different clinical types of X-linked adrenoleukodystrophy"],"prefix":"10.2152","volume":"70","author":[{"given":"Katsuya","family":"Morito","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Health Chemistry, Tokushima University Graduate School of Biomedical Sciences, Tokushima 770-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Health Chemistry, Tokushima University Graduate School of Biomedical Sciences, Tokushima 770-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanif","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Medical Pharmacology, Tokushima University Graduate School of Biomedical Sciences, Tokushima 770-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akina","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Health Chemistry, Tokushima University Graduate School of Biomedical Sciences, Tokushima 770-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Health Chemistry, Tokushima University Graduate School of Biomedical Sciences, Tokushima 770-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Health Chemistry, Tokushima University Graduate School of Biomedical Sciences, Tokushima 770-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Motiur","family":"Rahman","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Health Chemistry, Tokushima University Graduate School of Biomedical Sciences, Tokushima 770-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Health Chemistry, Tokushima University Graduate School of Biomedical Sciences, Tokushima 770-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Shimozawa","sequence":"additional","affiliation":[{"name":"Division of Genomics Research, Life Science Research Center, Gifu University, Gifu 501-1193, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiyasu","family":"Nakao","sequence":"additional","affiliation":[{"name":"Depertment of Molecular Medicinal Chemistry, Tokushima University Graduate School of Biomedical Sciences, Tokushima 770-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Sano","sequence":"additional","affiliation":[{"name":"Depertment of Molecular Medicinal Chemistry, Tokushima University Graduate School of Biomedical Sciences, Tokushima 770-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momoyo","family":"Azuma","sequence":"additional","affiliation":[{"name":"Department of Infection Control and Prevention, Tokushima University Hospital, Tokushima 770-8503, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Nanjundan","sequence":"additional","affiliation":[{"name":"Division of Bioscience and Bioindustry, Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima 770-8513, Japan"},{"name":"Department of Cell Biology, Microbiology, and Molecular Biology, University of South Florida, Tampa, Florida 33647, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Kogure","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Health Chemistry, Tokushima University Graduate School of Biomedical Sciences, Tokushima 770-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamotsu","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Health Chemistry, Tokushima University Graduate School of Biomedical Sciences, Tokushima 770-8505, Japan"},{"name":"Division of Bioscience and Bioindustry, Graduate School of Technology, Industrial and Social Sciences, Tokushima University, Tokushima 770-8513, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"925","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Engelen M, Kemp S, de Visser M, van Geel BM, Wanders RJ, Aubourg P, Poll-The BT:X-linked adrenoleukodystrophy (X-ALD):clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet J Rare Dis 7:51, 2012","DOI":"10.1186\/1750-1172-7-51"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ferrer I, Aubourg JP, Pujol A:General aspects and neuropathology of X-linked adrenoleukodystrophy. Brain Pathol 20:817-830, 2010","DOI":"10.1111\/j.1750-3639.2010.00390.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kemp S, Berger J, Aubourg P:X-linked adrenoleukodystrophy:clinical, metabolic, genetic and pathophysiological aspects. Biochim Biophys Acta 1822:1465-1474, 2012","DOI":"10.1016\/j.bbadis.2012.03.012"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Wiesinger C, Eichler FS, Berger J:The genetic landscape of X-linked adrenoleukodystrophy:inheritance, mutations, modifier genes, and diagnosis. Appl Clin Genet 8:109-121, 2015","DOI":"10.2147\/TACG.S49590"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kemp S, Wanders R:Biochemical Aspects of X-Linked Adrenoleukodystrophy. Brain Pathol 20:831-837, 2010","DOI":"10.1111\/j.1750-3639.2010.00391.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Moser AB, Fatemi A:Newborn Screening and Emerging Therapies for X-Linked Adrenoleukodystrophy. JAMA Neurol 75:1175-1176, 2018","DOI":"10.1001\/jamaneurol.2018.1585"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hannun YA, Obeid LM:Many ceramides. J Biol Chem 286:27855-27862, 2011","DOI":"10.1074\/jbc.R111.254359"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Levy M, Futerman AH:Mammalian ceramide synthases. IUBMB Life 62:347-356, 2010","DOI":"10.1002\/iub.319"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kitatani K, Idkowiak-Baldys J, Hannun YA:The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal 20:1010-1018, 2008","DOI":"10.1016\/j.cellsig.2007.12.006"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kihara A:Very long-chain fatty acids:elongation, physiology and related disorders. J Biochem 152:387-395, 2012","DOI":"10.1093\/jb\/mvs105"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. O\u2019Brien JS, Sampson EL:Fatty acid and fatty aldehyde composition of the major brain lipids in normal human gray matter, white matter, and myelin. J Lipid Res 6:545-551, 1965","DOI":"10.1016\/S0022-2275(20)39620-6"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Laviad EL, Albee L, Pankova-Kholmyansky I, Epstein S, Park H, Merrill AH Jr, Futerman AH:Characterization of ceramide synthase 2:tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate. J Biol Chem 283:5677-5684, 2008","DOI":"10.1074\/jbc.M707386200"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Becker I, Wang-Eckhardt L, Yaghootfam A, Gieselmann V, Eckhardt M:Differential expression of (dihydro) ceramide synthases in mouse brain:oligodendrocyte-specific expression of CerS2\/Lass2. Histochem Cell Biol 129:233-241, 2008","DOI":"10.1007\/s00418-007-0344-0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Canals D, Salamone S, Santacreu BJ, Nemeth E, Aguilar D, Hernandez-Corbacho MJ, Adada M, Staquicini DI, Arap W, Pasqualini R, Haley J, Obeid LM, Hannun YA:Ceramide launches an acute anti-adhesion pro-migration cell signaling program in response to chemotherapy. FASEB J 34:7610-7630, 2020","DOI":"10.1096\/fj.202000205R"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Gomez-Larrauri A, Presa N, Dominguez-Herrera A, Ouro A, Trueba M, Gomez-Mu?oz A:Role of bioactive sphingolipids in physiology and pathology. Essays Biochem 64:579-589, 2020","DOI":"10.1042\/EBC20190091"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hannun YA, Obeid LM:Sphingolipids and their metabolism in physiology and disease. Nat Rev 19:175-191, 2018","DOI":"10.1038\/nrm.2017.107"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Saddoughi SA, Ogretmen B:Diverse functions of ceramide in cancer cell death and proliferation. Adv Cencer Res 117:37-58, 2013","DOI":"10.1016\/B978-0-12-394274-6.00002-9"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kolesnick R:The therapeutic potential of modulating the ceramide\/sphingomyelin pathway. J Clin Invest 110:3-8, 2002","DOI":"10.1172\/JCI0216127"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Pettus BJ, Chalfant CE, Hannun YA:Ceramide in apoptosis:an overview and current perspectives. Biochem Biophys Acta 1585:114-125, 2002","DOI":"10.1016\/S1388-1981(02)00331-1"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Gr?sch S, Schiffmann S, Geisslinger G:Chain length-specific properties of ceramides. Prog Lipid Res 51:50-62, 2012","DOI":"10.1016\/j.plipres.2011.11.001"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Hoeferlin LA, Fekry B, Ogretmen B, Krupenko SA, Krupenko NI:Folate stress induces apoptosis via p53-dependent de novo ceramide synthesis and up-regulation of ceramide synthase 6. J Biol Chem 288:12880-12890, 2013","DOI":"10.1074\/jbc.M113.461798"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Mesicek J, Lee H, Feldman T, Jiang X, Skobeleva A, Berdyshev EV, Haimovitz-Friedman A, Fuks Z, Kolesnick R:Ceramide synthases 2, 5, and 6 confer distinct roles in radiation-induced apoptosis in HeLa cells. Cell Signal 22:1300-1307, 2010","DOI":"10.1016\/j.cellsig.2010.04.006"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Senkal CE, Ponnusamy S, Bielawski J, Hannun YA, Ogretmen B:Antiapoptotic roles of ceramide-synthase-6-generated C16-ceramide via selective regulation of the ATF6\/CHOP arm of ER-stress-response pathways. FASEB J 24:296-308, 2010","DOI":"10.1096\/fj.09-135087"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Siskind LJ, Mullen TD, Romero Rosales K, Clarke CJ, Hernandez-Corbacho MJ, Edinger AL, Obeid LM:The BCL-2 protein BAK is required for long-chain ceramide generation during apoptosis. J Biol Chem 285:11818-11826, 2010","DOI":"10.1074\/jbc.M109.078121"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. White-Gilbertson S, Mullen T, Senkal C, Lu P, Ogretmen B, Obeid L, Voelkel-Johnson C:Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase-3 in colon cancer cells. Oncogene 28:1132-1141, 2009","DOI":"10.1038\/onc.2008.468"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Osawa Y, Uchinami H, Bielawski J, Schwabe RF, Hannun YA, Brenner DA:Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-?. J Biol Chem 280:27879-27887, 2005","DOI":"10.1074\/jbc.M503002200"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Koybasi S, Senkal CE, Sundararaj K, Spassieva S, Bielawski J, Osta W, Day TA, Jiang JC, Jazwinski SM, Hannun YA, Obeid LM, Ogretmen B:Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas. J Biol Chem 279:44311-44319, 2004","DOI":"10.1074\/jbc.M406920200"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Kroesen BJ, Pettus B, Luberto C, Busman M, Sietsma H, de Leij L, Hannun YA:Induction of apoptosis through B-cell receptor cross-linking occurs via de novo generated C16-ceramide and involves mitochondria. J Biol Chem 276:13606-13614, 2001","DOI":"10.1074\/jbc.M009517200"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Memon RA, Holleran WM, Moser AH, Seki T, Uchida Y, Fuller J, Shigenaga JK, Grunfeld C, Feingold KR:Endotoxin and cytokines increase hepatic sphingolipid biosynthesis and produce lipoproteins enriched in ceramides and sphingomyelin. Arterioscler Thromb Vasc Biol 18:1257-1265, 1998","DOI":"10.1161\/01.ATV.18.8.1257"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Schumacher F, Carpinteiro A, Edwards MJ, Wilson GC, Keitsch S, Soddemann M, Wilker B, Kleuser B, Becker KA, M?ller CP, Kornhuber J, Gulbins E:Stress induces major depressive disorder by a neutral sphingomyelinase 2-mediated accumulation of ceramide-enriched exosomes in the blood plasma. J Mol Med 100:1493-1508, 2022","DOI":"10.1007\/s00109-022-02250-y"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Br?gger B, Simons M:Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 29:319 1244-1247, 2008","DOI":"10.1126\/science.1153124"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Boyanovsky B, Karakashian A, King K, Giltiay N, Nikolova-Karakashian M:Uptake and metabolism of low density lipoproteins with elevated ceramide content by human microvascular endothelial cells:implications for the regulation of apoptosis. J Biol Chem 278:26992-26999, 2003","DOI":"10.1074\/jbc.M301536200"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Wang G, Dinkins M, He Q, Zhu G, Poirier C, Campbell A, Mayer-Proschel M, Bieberich E:Astrocytes secrete exosomes enriched with proapoptotic ceramide and prostate apoptosis response 4 (PAR-4):potential mechanism of apoptosis induction in Alzheimer disease (AD). J Biol Chem 287:21384-2135, 2012","DOI":"10.1074\/jbc.M112.340513"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Moser HW, Moser AB, Frayer AB, Chen W, Schulman JD, O\u2019Neil BP, Kishimoto Y:Adrenoleukodystrophy:increased plasma content of saturated very long chain fatty acids. Neurology 31:1241-1249, 1981","DOI":"10.1212\/WNL.31.10.1241"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Bligh EG, Dyer WJ:A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917, 1959","DOI":"10.1139\/o59-099"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Bui HH, Leohr JK, Kuo MS:Analysis of sphingolipids in extracted human plasma using liquid chromatography electrospray ionization tandem mass spectrometry. Anal Biochem 423:187-194, 2012","DOI":"10.1016\/j.ab.2012.01.027"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Hammad SM, Pierce JS, Soodavar F, Smith KJ, Al Gadban MM, Rembiesa B, Klein RL, Hannun YA, Bielawski J, Bielawska A:Blood sphingolipidomics in healthy humans:impact of sample collection methodology. J Lipid Res 51:3074-3087, 2010","DOI":"10.1194\/jlr.D008532"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Richmond PA, van der Kloet F, Vaz FM, Lin D, Uzozie A, Graham E, Kobor M, Mostafavi S, Moerland PD, Lange PF, van Kampen AHC, Wasserman WW, Engelen M, Kemp S, van Karnebeek CDM:Multi-omic approach to identify phenotypic modifiers underlying cerebral demyelination in X-linked adrenoleukodystrophy. Front Cell Dev Biol 25:520, 2020","DOI":"10.1101\/2020.03.19.20035063"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Ali H, Kobayashi M, Morito K, Hasi RY, Aihara M, Hayashi J, Kawakami R, Tsuchiya K, Sango K, Tanaka T:Peroxisomes attenuate cytotoxicity of very long-chain fatty acids. Biochim Biophys Acta 1868:159259, 2023","DOI":"10.1016\/j.bbalip.2022.159259"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Lee DK, Long NP, Jung J, Kim TJ, Na E, Kang YP, Kwon SW, Jang J:Integrative lipidomic and transcriptomic analysis of X-linked adrenoleukodystrophy reveals distinct lipidome signatures between adrenomyeloneuropathy and childhood cerebral adrenoleukodystrophy. Biochem Biophys Res Commun 508:563-569, 2019","DOI":"10.1016\/j.bbrc.2018.11.123"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Raas Q, van de Beek MC, Forss-Petter S, Dijkstra IM, Deschiffart A, Freshner BC, Stevenson TJ, Jaspers YR, Nagtzaam L, Wanders RJ, van Weeghel M, Engelen-Lee JY, Engelen M, Eichler F, Berger J, Bonkowsky JL, Kemp S:Metabolic rerouting via SCD1 induction impacts X-linked adrenoleukodystrophy. J Clin Invest 131:e142500, 2021","DOI":"10.1172\/JCI142500"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Le?n-Aguilar LF, Croyal M, Ferchaud-Roucher V, Huang F, Marchat LA, Barraza-Villarreal A, Romieu I, Ramakrishnan U, Krempf M, Ouguerram K, Mercado-Camargo R, Bola?os-Jim?nez F:Maternal obesity leads to long-term altered levels of plasma ceramides in the offspring as revealed by a longitudinal lipidomic study in children. Int J Obes 43:1231-1243, 2019","DOI":"10.1038\/s41366-018-0291-y"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Henr?quez-Henr?quez MP, Solari S, Quiroga T, Kim BI, Deckelbaum RJ, Worgall TS:Low serum sphingolipids in children with attention deficit-hyperactivity disorder. Front Neurosci 9:300, 2015","DOI":"10.3389\/fnins.2015.00300"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Meeusen JW, Donato LJ, Bryant SC, Baudhuin LM, Berger PB, Jaffe AS:Plasma ceramides:a novel predictor of major adverse cardiovascular events after coronary angiography. Arterioscler Thromb Vasc Biol 38:1933-1939, 2018","DOI":"10.1161\/ATVBAHA.118.311199"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. McGrath ER, Himali JJ, Xanthakis V, Duncan MS, Schaffer JE, Ory DS, Peterson LR, DeCarli C, Pase MP, Satizabal CL, Vasan RS, Beiser AS, Seshadri S:Circulating ceramide ratios and risk of vascular brain aging and dementia. Ann Clin Transl Neurol 7:160-168, 2020","DOI":"10.1002\/acn3.50973"}],"container-title":["The Journal of Medical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/70\/3.4\/70_403\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T05:22:47Z","timestamp":1715577767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jmi\/70\/3.4\/70_403\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":45,"journal-issue":{"issue":"3.4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2152\/jmi.70.403","relation":{},"ISSN":["1343-1420","1349-6867"],"issn-type":[{"value":"1343-1420","type":"print"},{"value":"1349-6867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]}}}